Back to top

Image: Bigstock

Editas (EDIT) in Focus: Stock Moves 8.6% Higher

Read MoreHide Full Article

Editas Medicine, Inc. (EDIT - Free Report) was a big mover last session, as the company saw its shares rise nearly 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $25.01 to $30.88 in the past one-month time frame.

The company has seen no changes when it comes to estimate revision over the past few weeks, while the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Editas currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Editas Medicine, Inc. Price

Investors interested in the Medical - Biomedical and Genetics industry may consider Akcea Therapeutics, Inc. (AKCA - Free Report) , which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

5 Stocks to Soar Past the Pandemic: In addition to the companies you learned about above, we invite you to learn about 5 cutting-edge stocks that could skyrocket from the exponential increase in demand for “stay at home” technologies. This could be one of the biggest buying opportunities of the decade.

See the 5 high-tech stocks now>>


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Editas Medicine, Inc. (EDIT) - free report >>

Akcea Therapeutics, Inc. (AKCA) - free report >>

Published in